Covid19_manual_annotation  

PubMed:32610873 JSONTXT 23 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue ForCovid19 tao:has_database_id
3 48-66 Chemical denotes Hydroxychloroquine drug MESH:D006886
T2 73-76 Number denotes 522 trial criteria
4 77-85 Disease denotes COVID-19 MESH:C000657245
T3 86-98 Severity denotes hospitalized
5 99-107 Species denotes patients Tax:9606
T1 111-122 Area denotes Jaipur City
89 336-344 Disease denotes COVID-19 MESH:C000657245
90 345-354 Disease denotes infection MESH:D007239
T4 388-394 Area denotes Jaipur
T115 396-405 Area denotes Rajasthan
91 437-455 Chemical denotes hydroxychloroquine drug MESH:D006886
92 457-460 Chemical denotes HCQ drug MESH:D006886
93 478-486 Species denotes patients Tax:9606
94 527-535 Species denotes patients Tax:9606
95 541-549 Disease denotes COVID-19 MESH:C000657245
96 721-729 Disease denotes COVID-19 MESH:C000657245
T5 767-770 Number denotes 522 trial criteria
97 771-779 Species denotes patients Tax:9606
98 785-793 Species denotes patients Tax:9606
99 799-807 Disease denotes COVID-19 MESH:C000657245
T116 818-826 Positive denotes positive
T6 855-902 Method denotes Reverse Transcriptase Polymerase Chain Reaction MESH:D020133
T7 904-910 Method denotes RT-PCR MESH:D020133
T8 959-965 Area denotes Jaipur
100 987-994 Species denotes patient Tax:9606
101 1112-1120 Disease denotes COVID-19 MESH:C000657245
T9 1378-1381 Number denotes 522 trial criteria
104 1382-1390 Species denotes patients Tax:9606
105 1415-1423 Disease denotes COVID-19 MESH:C000657245
T133 1432-1438 Method denotes RT-PCR MESH:D020133
T11 1457-1463 Area denotes Jaipur
106 1514-1522 Species denotes patients Tax:9606
T12 1562-1585 Age denotes mean age of 35.42 years
T17 1587-1593 Percent denotes 22.41%
107 1594-1602 Species denotes patients Tax:9606
T13 1608-1629 Age denotes below 20 years of age
108 1643-1651 Species denotes patients Tax:9606
T18 1653-1659 Percent denotes 58.80%
T14 1673-1700 Age denotes age range of 21 to 50 years
T19 1710-1716 Percent denotes 18.79%
109 1717-1724 Species denotes patient Tax:9606
T15 1760-1774 Age denotes above 50 years
T20 1776-1783 Sex denotes Females
T21 1785-1791 Percent denotes 39.08%
T22 1817-1822 Sex denotes males
T23 1824-1830 Percent denotes 60.91%
T141 1840-1847 Average denotes average
T117 1848-1857 Index denotes sex ratio
T121 1861-1867 Sex denotes female
T122 1869-1873 Sex denotes male
T120 1880-1884 Ratio denotes 0.64
110 1912-1920 Species denotes patients Tax:9606
T24 1927-1933 Percent denotes 24.32%
111 1934-1942 Species denotes patients Tax:9606
T25 1948-1959 Condition denotes symptomatic
112 1972-1977 Disease denotes fever MESH:D005334
T26 1979-1985 Percent denotes 55.90%
113 1988-1993 Disease denotes cough MESH:D003371
T27 1995-2001 Percent denotes 52.75%
114 2004-2015 Disease denotes sore throat MESH:D010608
T28 2017-2023 Percent denotes 49.60%
115 2029-2048 Disease denotes shortness of breath MESH:D004417
T29 2050-2056 Percent denotes 46.45%
116 2126-2134 Species denotes patients Tax:9606
117 2156-2164 Disease denotes headache MESH:D006261
T30 2166-2172 Percent denotes 26.77%
118 2175-2185 Disease denotes chest pain MESH:D002637
T31 2187-2192 Percent denotes 6.29%
T33 2198-2212 Disease denotes other symptoms
T32 2214-2219 Percent denotes 7.87%
T34 2226-2238 Disease denotes pain abdomen MESH:D015746
120 2240-2247 Disease denotes fatigue MESH:D005221
121 2249-2260 Disease denotes joints pain MESH:D018771
T35 2262-2279 Disease denotes altered sensorium
122 2305-2313 Species denotes patients Tax:9606
T142 2347-2354 Average denotes average
T36 2358-2364 Percent denotes 40.40%
123 2365-2372 Species denotes patient Tax:9606
T37 2387-2408 Age denotes above 50 years of age
T123 2415-2426 Condition denotes symptomatic
T39 2433-2437 Negative denotes none
124 2445-2453 Species denotes patients Tax:9606
T38 2454-2475 Age denotes below 10 years of age
T124 2481-2492 Condition denotes symptomatic
T40 2494-2500 Percent denotes 13.98%
125 2501-2509 Species denotes patients Tax:9606
T41 2543-2552 Disease denotes co morbid comorbidity MESH:D015897
T51 2581-2593 Disease denotes co morbidity comorbidity MESH:D015897
126 2598-2610 Disease denotes hypertension comorbidity MESH:D006973
T42 2612-2618 Percent denotes 42.46%
127 2632-2649 Disease denotes Diabetes mellitus comorbidity MESH:D003920
T43 2651-2657 Percent denotes 39.72%
T49 2660-2671 Disease denotes Old k-chest comorbidity
T44 2673-2679 Percent denotes 20.54%
128 2682-2686 Disease denotes COPD comorbidity MESH:D029424
T50 2688-2704 Disease denotes Bronchial Asthma comorbidity MESH:D001249
T45 2706-2712 Percent denotes 16.43%
129 2715-2738 Disease denotes Coronary artery disease comorbidity MESH:D003324
T46 2740-2746 Percent denotes 13.69%
130 2749-2771 Disease denotes Chronic kidney disease comorbidity MESH:D051436
T47 2773-2779 Percent denotes 13.69%
131 2785-2807 Disease denotes Valvular heart disease comorbidity MESH:D006349
T48 2809-2814 Percent denotes 6.84%
132 2841-2849 Species denotes patients Tax:9606
133 2853-2861 Disease denotes COVID-19 MESH:C000657245
T52 2863-2869 Percent denotes 60.27%
134 2873-2880 Species denotes patient Tax:9606
T128 2908-2917 Disease denotes co morbid comorbidity MESH:D015897
T68 2918-2928 Condition denotes conditions comorbidity
T131 2934-2938 PositiveRegulation denotes more
T129 2956-2970 Condition denotes symptomatology
T130 2971-2978 Condition denotes complex
T126 3011-3019 Species denotes patients Tax:9606
T127 3025-3027 Negative denotes no
T108 3028-3040 Disease denotes co morbidity comorbidity MESH:D015897
T109 3042-3048 Percent denotes 18.42%
T114 3051-3054 Number denotes 116 trial criteria
136 3055-3063 Species denotes patients Tax:9606
T132 3068-3077 BecomeReduce denotes recovered
T110 3083-3102 Therapy denotes effective treatment
T134 3247-3253 Method denotes RT-PCR MESH:D020133
137 3258-3266 Disease denotes COVID-19 MESH:C000657245
T143 3275-3282 Average denotes average
T140 3283-3291 BecomeReduce denotes recovery
T55 3300-3309 Period denotes 8.15 days
T58 3311-3317 Percent denotes 23.27%
138 3318-3326 Species denotes patients Tax:9606
T135 3327-3336 BecomeReduce denotes recovered
T59 3337-3350 Period denotes within 5 days
T60 3358-3364 Percent denotes 52.58%
139 3365-3373 Species denotes patients Tax:9606
T136 3374-3378 BecomeReduce denotes took
T61 3379-3394 Period denotes about 6-10 days
T62 3396-3402 Percent denotes 23.27%
140 3403-3411 Species denotes patients Tax:9606
T137 3412-3416 BecomeReduce denotes took
T63 3417-3427 Period denotes 11-15 days
T64 3442-3447 Percent denotes 0.86%
T138 3448-3452 BecomeReduce denotes took
T65 3453-3470 Period denotes more than 16 days
T107 3504-3506 Number denotes 15
141 3507-3515 Species denotes patients Tax:9606
142 3520-3524 Die denotes died MESH:D003643
T66 3568-3574 Percent denotes 73.33%
T67 3580-3600 Age denotes above 50 year of age
T70 3608-3612 Sex denotes male
T71 3628-3633 Percent denotes 66.6%
T144 3655-3663 Die denotes deceased MESH:D003643
T75 3665-3669 Percent denotes 100%
T148 3690-3713 Condition denotes clinical manifestations
143 3717-3725 Disease denotes COVID-19 MESH:C000657245
T145 3749-3757 Condition denotes multiple
T147 3758-3767 Disease denotes co morbid comorbidity MESH:D015897
T72 3768-3778 Condition denotes conditions
144 3792-3800 Species denotes patients Tax:9606
145 3811-3820 Die denotes mortality MESH:D009026
T153 3827-3848 Timing denotes admission to hospital
T77 3854-3863 Ratio denotes two third
146 3864-3869 Die denotes death MESH:D003643
T78 3881-3899 Period denotes initial three days
T159 3901-3913 Condition denotes Asymptomatic
147 3914-3922 Species denotes patients Tax:9606
T162 3931-3938 Therapy denotes treated
148 3944-3947 Chemical denotes HCQ drug MESH:D006886
T163 3948-3963 GoodEffect denotes recovered early
T154 3965-3972 Average denotes average
T155 3973-3981 BecomeReduce denotes recovery
T79 3988-3996 Period denotes 5.4 days
T160 4010-4022 Condition denotes asymptomatic
149 4023-4031 Species denotes patients Tax:9606
T161 4040-4043 Negative denotes not
T82 4052-4065 Therapy denotes any treatment
T156 4112-4119 Average denotes average
T157 4120-4128 BecomeReduce denotes recovery
T81 4135-4143 Period denotes 7.6 days
150 4180-4188 Disease denotes COVID-19 MESH:C000657245
T164 4196-4203 BadEffect denotes affects
T83 4204-4219 Age denotes young adult age
T84 4227-4257 Age denotes third to fifth decades of life
T85 4275-4284 Age denotes early age different
T165 4300-4308 BadEffect denotes affected
T86 4372-4387 Area denotes other countries
T88 4410-4414 Sex denotes male
T166 4443-4447 PositiveRegulation denotes more
151 4465-4473 Disease denotes infected MESH:D007239
152 4487-4495 Disease denotes COVID-19 MESH:C000657245
T167 4496-4504 Chemical denotes positive
153 4505-4513 Species denotes patients Tax:9606
T89 4515-4534 Ratio denotes nearly three-fourth
T90 4541-4553 Condition denotes asymptomatic
T168 4565-4574 Age denotes young age
T169 4597-4606 Timing denotes diagnosis
154 4663-4668 Disease denotes Fever MESH:D005334
155 4670-4675 Disease denotes cough MESH:D003371
156 4677-4688 Disease denotes sore throat MESH:D010608
157 4693-4712 Disease denotes shortness of breath MESH:D004417
T170 4724-4732 Condition denotes symptoms
158 4764-4772 Disease denotes COVID-19 MESH:C000657245
159 4773-4781 Species denotes patients Tax:9606
T91 4783-4794 Condition denotes Symptomatic
T92 4839-4846 Age denotes old age
T113 4859-4870 Infection denotes Infectivity
T176 4875-4881 Increase denotes higher
160 4885-4893 Species denotes patients Tax:9606
T171 4914-4923 Disease denotes co morbid comorbidity MESH:D015897
T177 4933-4943 PositiveRegulation denotes especially
161 4947-4955 Species denotes patients Tax:9606
T93 4961-4969 Condition denotes multiple
T172 4970-4979 Disease denotes co morbid comorbidity MESH:D015897
T175 4980-4990 Condition denotes conditions
T94 4992-5003 Condition denotes Symptomatic
162 5020-5028 Disease denotes COVID-19 MESH:C000657245
T178 5048-5054 PositiveRegulation denotes higher
163 5058-5066 Species denotes patients Tax:9606
T173 5072-5081 Disease denotes co morbid comorbidity MESH:D015897
T158 5091-5098 Average denotes Average
T96 5099-5107 BecomeReduce denotes recovery
164 5118-5126 Disease denotes COVID-19 MESH:C000657245
T97 5131-5137 Period denotes 8 days
T98 5143-5162 Therapy denotes effective treatment
T149 5164-5173 Die denotes Mortality MESH:D009026
166 5177-5185 Disease denotes COVID-19 MESH:C000657245
T179 5190-5196 Increase denotes higher
T99 5200-5207 Age denotes old age
T100 5220-5224 Sex denotes male
T101 5233-5244 Condition denotes symptomatic
T174 5249-5258 Disease denotes co morbid comorbidity MESH:D015897
167 5259-5267 Species denotes patients Tax:9606
T150 5322-5331 Die denotes mortality MESH:D009026
T104 5349-5363 Period denotes first few days
T180 5367-5376 Timing denotes admission
T151 5398-5407 Die denotes mortality MESH:D009026
T103 5419-5434 Disease denotes primary disease
T106 5444-5453 Therapy denotes Treatment
170 5459-5462 Chemical denotes HCQ drug MESH:D006886
T181 5467-5481 GoodEffect denotes early recovery
T105 5482-5489 Negative denotes without
T182 5502-5513 BadEffect denotes influencing
T152 5526-5535 Die denotes mortality MESH:D009026
R100 T7 T6 abbreviation RT-PCR,Reverse Transcriptase Polymerase Chain Reaction
R101 T6 T116 using Reverse Transcriptase Polymerase Chain Reaction,positive
R102 T116 99 is_a positive,COVID-19
R103 99 98 has_a COVID-19,patients
R104 105 104 has_a COVID-19,patients
R105 T12 106 is_a mean age of 35.42 years,patients
R106 T13 107 is_a below 20 years of age,patients
R107 T14 108 is_a age range of 21 to 50 years,patients
R108 108 T18 of_a patients,58.80%
R109 T15 109 is_a above 50 years,patient
R110 T120 T117 of_a 0.64,sex ratio
R111 T121 T117 relates female,sex ratio
R112 T122 T117 against male,sex ratio
R114 111 T24 of_a patients,24.32%
R115 111 T25 has_status patients,symptomatic
R116 T24 T26 in 24.32%,55.90%
R117 T24 T27 in 24.32%,52.75%
R118 T24 T28 in 24.32%,49.60%
R119 T24 T29 in 24.32%,46.45%
R12 T20 T21 of_a Females,39.08%
R120 T24 T30 in 24.32%,26.77%
R121 T24 T31 in 24.32%,6.29%
R122 T24 T32 in 24.32%,7.87%
R123 T34 T33 is_a pain abdomen,other symptoms
R124 120 T33 of_a fatigue,other symptoms
R125 120 T33 is_a fatigue,other symptoms
R126 121 T33 is_a joints pain,other symptoms
R127 T35 T33 is_a altered sensorium,other symptoms
R128 123 T36 of_a patient,40.40%
R129 T37 123 is_a above 50 years of age,patient
R13 T22 T23 of_a males,60.91%
R130 123 T123 has_status patient,symptomatic
R131 T38 124 is_a below 10 years of age,patients
R132 124 T124 has_status patients,symptomatic
R133 T39 T124 is_a none,symptomatic
R134 125 T40 of_a patients,13.98%
R135 T41 125 has_a co morbid,patients
R136 T40 T42 in 13.98%,42.46%
R137 T40 T43 in 13.98%,39.72%
R138 T40 T44 in 13.98%,20.54%
R139 T40 T45 in 13.98%,16.43%
R140 T40 T46 in 13.98%,13.69%
R141 T40 T47 in 13.98%,13.69%
R142 T40 T48 in 13.98%,6.84%
R143 133 132 has_a COVID-19,patients
R144 T126 T109 of_a patients,18.42%
R145 134 T52 of_a patient,60.27%
R146 T127 T108 is_a no,co morbidity
R147 T108 T126 has_a co morbidity,patients
R148 134 T68 has_status patient,conditions
R149 T128 T68 of_a co morbid,conditions
R150 T130 T129 of_a complex,symptomatology
R151 T131 T130 is_a more,complex
R152 T68 T129 has_status conditions,symptomatology
R153 T126 T131 against patients,more
R154 136 T132 is_a patients,recovered
R155 T110 T132 with effective treatment,recovered
R156 138 T58 of_a patients,23.27%
R157 139 T60 of_a patients,52.58%
R158 138 T135 is_a patients,recovered
R159 139 T136 is_a patients,took
R160 T59 T135 in within 5 days,recovered
R161 140 T62 of_a patients,23.27%
R162 140 T137 is_a patients,took
R163 T63 T137 in 11-15 days,took
R164 T61 T136 in about 6-10 days,took
R165 T64 T138 is_a 0.86%,took
R166 T65 T138 in more than 16 days,took
R167 T55 T140 in 8.15 days,recovery
R168 T141 T117 of_a average,sex ratio
R169 T142 T36 of_a average,40.40%
R170 T143 T140 of_a average,recovery
R171 141 T107 of_a patients,15
R172 T107 T66 in 15,73.33%
R173 T67 T66 is_a above 50 year of age,73.33%
R174 T66 T71 in 73.33%,66.6%
R175 T75 T144 is_a 100%,deceased
R176 T147 T72 of_a co morbid,conditions
R177 T145 T147 of_a multiple,co morbid
R178 143 T148 of_a COVID-19,clinical manifestations
R179 T75 T148 has_status 100%,clinical manifestations
R180 T75 T72 has_status 100%,conditions
R181 T78 146 in initial three days,death
R182 T107 T77 in 15,two third
R183 T153 T78 of_a admission to hospital,initial three days
R184 T154 T155 of_a average,recovery
R185 T79 T155 in 5.4 days,recovery
R186 T156 T157 of_a average,recovery
R187 T81 T157 in 7.6 days,recovery
R188 T158 T96 of_a Average,recovery
R189 T97 T96 in 8 days,recovery
R19 T26 112 has_a 55.90%,fever
R190 147 T159 has_status patients,Asymptomatic
R191 149 T160 has_status patients,asymptomatic
R192 T162 147 with treated,patients
R193 148 T162 with HCQ,treated
R194 T82 149 with any treatment,patients
R195 T161 T82 is_a not,any treatment
R196 T155 147 is_a recovery,patients
R197 T157 149 is_a recovery,patients
R198 T79 T163 abbreviation 5.4 days,recovered early
R199 T81 T163 against 7.6 days,recovered early
R2 97 T5 of_a patients,522
R20 T27 113 has_a 52.75%,cough
R200 150 T164 is_a COVID-19,affects
R201 T164 T83 is_a affects,young adult age
R202 T84 T83 is_a third to fifth decades of life,young adult age
R203 T165 T85 is_a affected,early age
R204 T86 T85 against other countries,early age
R205 151 T88 has_a infected,male
R206 T166 151 of_a more,infected
R207 T167 152 is_a positive,COVID-19
R208 152 153 has_a COVID-19,patients
R209 153 T89 of_a patients,nearly three-fourth
R21 T29 115 has_a 46.45%,shortness of breath
R210 T168 153 is_a young age,patients
R211 T169 T90 of_a diagnosis,asymptomatic
R212 153 T90 has_status patients,asymptomatic
R213 158 159 has_a COVID-19,patients
R214 158 T170 of_a COVID-19,symptoms
R215 154 T170 is_a Fever,symptoms
R216 155 T170 is_a cough,symptoms
R217 156 T170 is_a sore throat,symptoms
R218 157 T170 is_a shortness of breath,symptoms
R219 T93 T172 of_a multiple,co morbid
R22 T28 114 has_a 49.60%,sore throat
R220 T172 T175 of_a co morbid,conditions
R221 161 T175 has_status patients,conditions
R222 T171 160 has_a co morbid,patients
R223 T113 T176 is_a Infectivity,higher
R224 160 T176 in patients,higher
R225 161 T176 in patients,higher
R226 T177 161 is_a especially,patients
R227 162 163 has_a COVID-19,patients
R228 T173 163 has_a co morbid,patients
R229 T178 T94 is_a higher,Symptomatic
R23 T30 117 has_a 26.77%,headache
R230 164 T96 from COVID-19,recovery
R231 T98 T96 with effective treatment,recovery
R232 T99 167 is_a old age,patients
R233 T100 167 is_a male,patients
R234 167 T101 has_status patients,symptomatic
R235 T174 167 has_a co morbid,patients
R236 167 T149 is_a patients,Mortality
R237 166 167 has_a COVID-19,patients
R238 T149 T179 is_a Mortality,higher
R239 T180 T104 of_a admission,first few days
R24 T31 118 has_a 6.29%,chest pain
R240 T104 T150 in first few days,mortality
R241 170 T106 with HCQ,Treatment
R242 T106 T181 is_a Treatment,early recovery
R243 T105 T182 is_a without,influencing
R244 T105 T181 is_a without,early recovery
R245 T152 T182 for mortality,influencing
R25 T32 T33 has_a 7.87%,other symptoms
R3 104 T9 of_a patients,522
R37 T42 126 has_a 42.46%,hypertension
R38 T43 127 has_a 39.72%,Diabetes mellitus
R39 T46 129 has_a 13.69%,Coronary artery disease
R40 T47 130 has_a 13.69%,Chronic kidney disease
R41 T48 131 has_a 6.84%,Valvular heart disease
R42 T44 T49 has_a 20.54%,Old k-chest
R43 T45 T50 has_a 16.43%,Bronchial Asthma
R44 T45 128 has_a 16.43%,COPD
R53 141 142 is_a patients,died
R54 T70 T71 is_a male,66.6%
R59 T77 146 is_a two third,death
R7 109 T19 of_a patient,18.79%
R70 T92 T91 has_status old age,Symptomatic
R73 163 T94 has_status patients,Symptomatic
R8 107 T17 of_a patients,22.41%
R94 136 T114 of_a patients,116
R95 4 5 has_a COVID-19,patients
R96 5 T2 of_a patients,522
R97 T3 5 of_a hospitalized,patients
R98 92 91 abbreviation HCQ,hydroxychloroquine
R99 89 90 of_a COVID-19,infection